Latest News

Newly identified antibodies effectively treat Alzheimer's-like disease in mice

Alzheimer's disease is characterized by the accumulation of particular toxic proteins in the brain that are believed to underlie the cognitive decline in patients. A new study conducted in mice suggests that newly identified antibody treatments can prevent the accumulation of one of these of these toxic components, called tau proteins. The findings suggest that these antibodies may provide a basis for a promising therapy for patients with Alzheimer's disease and other neurodegenerative disorders.
View full story

Post your comment.


  • Should women consume alcohol during pregnancy?

  • Extremely active rats become lazy when they artificially receive 'runners' high'

  • Youngest students in class 30% more likely to die in suicide than older classmates, Japanese study shows

  • Repeating aloud to another person boosts recall

  • American placebo: New analysis of chronic pain drug trials shows increasing placebo responses over time, in the US only

  • Understanding others' thoughts enables young kids to lie

  • Mutation involved in neurodegeneration discovered

  • How dominant parents affect kids' self-worth

  • Virus-drug combination shows improved effectiveness against brain tumor cells

  • Risk profiling is key to managing pain in era of opioid abuse